Meta-analysis of low molecular weight heparin to prevent recurrent placenta-mediated pregnancy complications.

Abstract : : A 35 year old woman with recurrent severe placenta mediated pregnancy complications in her 2 pregnancies asks: Will low molecular weight heparin help prevent recurrent placenta mediated pregnancy complications in my next pregnancy? We performed a meta-analysis of randomised controlled trials (RCTs) comparing low molecular weight heparin (LMWH) versus no LMWH for the prevention of recurrent placenta-mediated pregnancy complications. We identified six RCTs, including a total of 848 pregnant women with prior placenta-mediated pregnancy complications. The primary outcome was a composite of PE, birth of a SGA newborn (<10th percentile), placental abruption, or pregnancy loss >20 weeks. Overall, 67/358 (18.7%) of women on prophylactic LMWH had recurrent severe placenta-mediated pregnancy complications, as compared with 127/296 (42.9%) women with no LMWH [relative risk reduction 0.52 (95% CI 0.32-0.86) (p=0.01) (I(2) 69% indicating moderate heterogeneity)]. We identified similar relative risk reductions with LMWH for individual outcomes including any PE, severe PE, SGA <10th, SGA <5th, preterm delivery <37 weeks and preterm delivery <34 weeks with minimal heterogeneity. Low molecular weight heparin may be a promising therapy for recurrent, especially severe, placenta mediated pregnancy complications but further research is required.
Type de document :
Article dans une revue
Blood, American Society of Hematology, 2013, epub ahead of print. 〈10.1182/blood-2013-01-478958〉
Liste complète des métadonnées

http://hal.univ-brest.fr/hal-00935578
Contributeur : Ghislaine Calvez <>
Soumis le : jeudi 23 janvier 2014 - 16:40:02
Dernière modification le : mercredi 10 janvier 2018 - 14:42:02

Lien texte intégral

Identifiants

Collections

Citation

Marc A Rodger, Marc Carrier, Grégoire Le Gal, Ida Martinelli, Annalisa Perna, et al.. Meta-analysis of low molecular weight heparin to prevent recurrent placenta-mediated pregnancy complications.. Blood, American Society of Hematology, 2013, epub ahead of print. 〈10.1182/blood-2013-01-478958〉. 〈hal-00935578〉

Partager

Métriques

Consultations de la notice

88